NO953461D0 - Faste lipidpartikler, slike partikler omfattende bioaktive midler samt fremstilling og bruk derav - Google Patents

Faste lipidpartikler, slike partikler omfattende bioaktive midler samt fremstilling og bruk derav

Info

Publication number
NO953461D0
NO953461D0 NO953461A NO953461A NO953461D0 NO 953461 D0 NO953461 D0 NO 953461D0 NO 953461 A NO953461 A NO 953461A NO 953461 A NO953461 A NO 953461A NO 953461 D0 NO953461 D0 NO 953461D0
Authority
NO
Norway
Prior art keywords
particles
suspensions
preparation
lipid
solid lipid
Prior art date
Application number
NO953461A
Other languages
English (en)
Other versions
NO953461L (no
NO314285B1 (no
Inventor
Kirsten Westesen
Britta Siekmann
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO953461D0 publication Critical patent/NO953461D0/no
Publication of NO953461L publication Critical patent/NO953461L/no
Publication of NO314285B1 publication Critical patent/NO314285B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B01F23/4105—Methods of emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/48—Mixing liquids with liquids; Emulsifying characterised by the nature of the liquids
    • B01F23/482—Mixing liquids with liquids; Emulsifying characterised by the nature of the liquids using molten solids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/50—Mixing liquids with solids
    • B01F23/51—Methods thereof
    • B01F23/511—Methods thereof characterised by the composition of the liquids or solids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Geometry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19953461A 1993-03-05 1995-09-04 Fremgangsmåte ved emulgering av uopplöselige eller dårlig opplöselige materialer samt suspensjon dannet ved fremgangsmåten, partikler oganvendelse NO314285B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2750193A 1993-03-05 1993-03-05
CA002091152A CA2091152C (en) 1993-03-05 1993-03-05 Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
PCT/SE1994/000185 WO1994020072A1 (en) 1993-03-05 1994-03-04 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof

Publications (3)

Publication Number Publication Date
NO953461D0 true NO953461D0 (no) 1995-09-04
NO953461L NO953461L (no) 1995-11-06
NO314285B1 NO314285B1 (no) 2003-03-03

Family

ID=25675967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19953461A NO314285B1 (no) 1993-03-05 1995-09-04 Fremgangsmåte ved emulgering av uopplöselige eller dårlig opplöselige materialer samt suspensjon dannet ved fremgangsmåten, partikler oganvendelse

Country Status (13)

Country Link
EP (1) EP0687172B1 (no)
JP (2) JP3916249B2 (no)
AT (1) ATE228821T1 (no)
AU (1) AU676279B2 (no)
CA (1) CA2091152C (no)
DE (1) DE69431831T2 (no)
DK (1) DK0687172T3 (no)
ES (1) ES2190439T3 (no)
FI (1) FI114006B (no)
NO (1) NO314285B1 (no)
NZ (1) NZ262541A (no)
PT (1) PT687172E (no)
WO (1) WO1994020072A1 (no)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
PT101422B (pt) * 1993-12-06 1997-06-30 Ineti Inst Biotec Q F E Tecnol Formulacoes lipossomicas contendo vidarabina e/ou derivados, com indice terapeutico elevado e processo para a sua preparacao
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
CA2213638C (en) * 1995-02-24 2004-05-04 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
KR100542816B1 (ko) * 1996-08-22 2006-01-11 알티피 파마 코포레이션 수불용성 물질의 미립자를 포함하는 조성물 및 이것의 제조 방법
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
JP4155600B2 (ja) 1996-10-25 2008-09-24 モンサント・テクノロジー・エルエルシー 外因性化学物質を用いて植物を処置するための化合物及び方法
ES2172774T3 (es) * 1996-10-25 2002-10-01 Monsanto Technology Llc Composiciones y procedimiento para el tratamiento de plantas con sustancias quimicas exogenas.
GB9624615D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Chrystallisation process
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
US6423363B1 (en) 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
AU1809499A (en) * 1997-12-10 1999-06-28 Awadhesh K. Mishra Self-emulsifying fenofibrate formulations
IT1298575B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
SE512958C2 (sv) † 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
GB9810859D0 (en) 1998-05-20 1998-07-22 Zeneca Ltd Crystallisation process
ATE258008T1 (de) * 1998-06-17 2004-02-15 Uniroyal Chem Co Inc Biologisch aktive mikrodispersionszusammensetzung
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
AU767154B2 (en) 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
IT1303787B1 (it) * 1998-11-25 2001-02-23 Maria Rosa Gasco "nanosfere lipidiche solide atte ad una rapida internalizzazione nellecellule"
DE19919770A1 (de) * 1999-04-30 2000-11-02 Henkel Kgaa Verwendung nanoskaliger antimikrobieller Wirkstoffe in der Mund- und/oder Zahnpflege
SE517769C2 (sv) 1999-10-29 2002-07-16 Triple Crown Ab Kolesterol och blodfettsänkande komposition, innehållande fytosteroler, blandade med monoglycerider
KR20020026053A (ko) 2000-09-30 2002-04-06 노승권 음료용 식물성 스테롤의 분산방법 및 이를 함유하는 음료
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
EP1480661B1 (de) 2002-02-28 2011-04-13 Heitland & Petre International GmbH Mikro-/nanopartikel aus lipidhaltigen marinen organismen für pharmazie und kosmetik
AU2002241368B2 (en) * 2002-03-20 2009-07-09 Eugene Science Inc. Plant sterol-containing food, and method for preparing the same
JP4452970B2 (ja) 2002-03-27 2010-04-21 日本臓器製薬株式会社 ジクロフェナクナトリウム経口製剤
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
ITMI20021725A1 (it) * 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
JP2006524632A (ja) 2002-12-09 2006-11-02 アメリカン バイオサイエンス、インコーポレイテッド 組成物及び薬物送達方法
DE10312763A1 (de) * 2003-03-21 2004-09-30 IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG Verfahren zur Herstellung einer SLN-Dispersion
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
JP2004323444A (ja) * 2003-04-25 2004-11-18 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 凍結乾燥微粒子製剤およびその製法
US7438903B2 (en) 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
JP2007503418A (ja) 2003-08-27 2007-02-22 バイヤースドルフ・アクチエンゲゼルシヤフト 局所使用中に個別には感知不能になる外皮を有するカプセル
DE10357639A1 (de) 2003-08-27 2005-03-24 Beiersdorf Ag Kosmetische und/oder dermatologische Kapsel
US8741320B2 (en) 2003-08-27 2014-06-03 Beiersdorf Ag Spherical cosmetic preparations for topical application
JP2005097295A (ja) * 2003-09-01 2005-04-14 Wakunaga Pharmaceut Co Ltd ビタミン安定液剤
US7611733B2 (en) 2004-03-26 2009-11-03 Cell Therapeutics Europe S.R.L. Nanoparticle formulations of platinum compounds
US7803366B2 (en) 2004-05-07 2010-09-28 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
EP1674085A1 (en) * 2004-12-22 2006-06-28 Universite Libre De Bruxelles Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation
KR20130079645A (ko) * 2005-07-18 2013-07-10 유니버시티 오브 메사츄세츠 로웰 나노에멀젼 조성물 및 이의 제조 및 사용 방법
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US7943666B2 (en) 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
SG177184A1 (en) 2006-12-01 2012-01-30 Anterios Inc Amphiphilic entity nanoparticles
BRPI0719732A2 (pt) 2006-12-01 2017-05-16 Anterios Inc nanopartículas de peptídeo e usos para as mesmas
WO2008102065A1 (fr) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Emulsions fluorescentes pour l'imagerie optique
EP3398611B1 (en) 2007-04-18 2020-08-12 Particle Sciences, Inc. Aerosol dispersions of particles with active pharmaceutical ingredients
CN103961315A (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
JP5468271B2 (ja) * 2008-02-08 2014-04-09 花王株式会社 微粒子分散液の製造方法
DE102008035442A1 (de) 2008-07-26 2010-01-28 Ernst-Moritz-Arndt-Universität Greifswald Zubereitungen aus Artemisia Annua, ihre Umwandlung in Mikro- und Nanopartikel und ihre Verwendung
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934954B1 (fr) * 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
RU2535017C2 (ru) 2008-09-19 2014-12-10 Активус Фарма Ко., Лтд. Композитный порошок из органического вещества для применения в медицине, способ его получения и его суспензия
CA2763456C (en) 2009-05-27 2017-10-24 Alkermes Pharma Ireland Limited Reduction of flake-like aggregation in nanoparticulate active agent compositions
WO2011139899A2 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
WO2012059936A1 (en) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Pharmaceutical compositions for colloidal drug delivery
WO2013105026A1 (en) * 2012-01-09 2013-07-18 Department Of Biotechnology (Dbt) A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2014054172A1 (ja) * 2012-10-05 2014-04-10 株式会社原田食品 ゾル状低カロリー食品素材および包装容器体入ゾル状低カロリー食品素材およびそれらの製造方法
CN104822372A (zh) * 2012-11-30 2015-08-05 英斯梅德股份有限公司 前列环素组合物及其使用方法
EP2823811A1 (en) * 2013-07-09 2015-01-14 OTC GmbH Targeted active release system comprising solid lipid nano-particles
CA2927788C (en) 2013-10-25 2022-09-06 Insmed Incorporated Prostacyclin compounds, compositions and methods of use thereof
IN2014CH01872A (no) 2014-04-09 2015-05-08 Nanoceutica Lab Pvt Ltd
WO2016081658A1 (en) 2014-11-18 2016-05-26 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
CN110225975A (zh) 2016-08-23 2019-09-10 阿库斯股份有限公司 用于治疗人受试者中非年龄相关的听力损害的组合物和方法
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
CA3138530A1 (en) 2019-04-29 2020-11-05 Insmed Incorporated Dry powder compositions of treprostinil prodrugs and methods of use thereof
CN114867363A (zh) * 2019-12-10 2022-08-05 比利时胶囊公司 含脂质基质核心和活性成分的颗粒
JP2023515072A (ja) 2020-02-21 2023-04-12 アコーオス インコーポレイテッド ヒト対象において非加齢関連聴力障害を処置するための組成物および方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
DK0502119T3 (da) * 1989-11-13 1996-06-03 Abraham J Domb Liposfærer til kontrolleret frigivelse af substanser
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles

Also Published As

Publication number Publication date
WO1994020072A1 (en) 1994-09-15
FI954143A (fi) 1995-10-19
PT687172E (pt) 2003-04-30
JP2007023051A (ja) 2007-02-01
DE69431831D1 (de) 2003-01-16
JP3916249B2 (ja) 2007-05-16
JPH08507515A (ja) 1996-08-13
AU676279B2 (en) 1997-03-06
DE69431831T2 (de) 2003-04-10
FI954143A0 (fi) 1995-09-04
EP0687172B1 (en) 2002-12-04
NO953461L (no) 1995-11-06
ES2190439T3 (es) 2003-08-01
AU6225394A (en) 1994-09-26
CA2091152C (en) 2005-05-03
NO314285B1 (no) 2003-03-03
EP0687172A1 (en) 1995-12-20
ATE228821T1 (de) 2002-12-15
FI114006B (fi) 2004-07-30
CA2091152A1 (en) 1994-09-06
DK0687172T3 (da) 2003-03-17
NZ262541A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
NO953461L (no) Faste lipidpartikler, slike partikler omfattende bioaktive midler samt fremstilling og bruk derav
Benoit et al. Preparation and characterization of protein-loaded poly (ε-caprolactone) microparticles for oral vaccine delivery
Swaan Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways
AR010758A1 (es) Composicion de ibuprofeno que comprende uno o mas medicamentos, preparacion acuosa de dosis unitaria, proceso para preparar dicha preparacion acuosa,proceso para preparar dicha composicion de ibuprofeno, y uso de dicha preparacion
Latha et al. Progesterone release from glutaraldehyde cross-linked casein microspheres: in vitro studies and in vivo response in rabbits
GB2237510B (en) Small particle drug compositions for nasal administration
JP2594560B2 (ja) 巨大分子ポリペプチドの放出速度調節
Menei et al. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres
DK0711151T3 (da) Partikler med modificerede fysisk-kemiske egenskaber, deres fremstilling og anvendelser
WO2001035932A3 (en) Sustained drug delivery from structural matrices
FI102811B1 (fi) Menetelmä vaikuttavaa ainetta sisältävien mikropartikkeleiden valmistamiseksi hydrolyyttisesti hajoavista polymeereistä
CA2292586A1 (en) Solid pharmaceutical dosage forms in form of a particulate dispersion
DE69428040D1 (de) Orale darreichungsform
CN101801358A (zh) 治疗性稳定的纳米颗粒
MXPA06011171A (es) Aplicacion ex-vivo de agentes terapeuticos microparticulados solidos.
Raghuvanshi et al. Stabilization of dichloromethane-induced protein denaturation during microencapsulation
NL300330I2 (nl) Preparaat voor het afgeven van peptiden
JPH062224B2 (ja) 極小粒子形の蛋白質の分散性コロイド系の調製方法
Byeon et al. PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy
DE60018629D1 (de) Carbamazepinformulierung mit verzögerter Freigabe
US20040146564A1 (en) Process for making delivery matrix and uses thereof
JP2789115B2 (ja) 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法
Beyatricks et al. RECENT TRENDS IN MICROSPHERE DRUG DELIVERY SYSTEM AND ITS THERAPEUTIC APPLICATIONS–A
Agrawal et al. Parenteral delivery of peptides and proteins
WO2000013666A1 (en) Biodegradable particulate polymeric preparation and process for producing thereof